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The GET pathway, using several proteins (Gets 1-5 and probably Sgt2), posttranslationally conducts tail-
anchored (TA) proteins to the endoplasmic reticulum (ER). At the ER, TA proteins are inserted into the lipid
bilayer and then sorted and directed to their respective destinations in the secretory pathway. Until last
year, there was no structural information on any of the GET components but now there are ten crystal struc-
tures of Get3 in a variety of nucleotide-bound states and conformations. The structures of Get4 and a portion
of Get5 also emerged in 2010. This minireview provides a detailed comparison of the GET structures and
discusses their mechanistic relevance to TA protein insertion. It also addresses the outstanding gaps in
detailedmolecular information on this system, including the structures of Get5, Sgt2, and the transmembrane
complex comprising Get1 and Get2.Introduction
A large proportion of cellular proteins reside within membrane
bilayers and pose a particular challenge to the cell, in that they
are synthesized in the aqueous cytoplasm where their hydro-
phobic transmembrane portions must be protected until delivery
to the requisite membrane. For most membrane proteins, this is
solved by cotranslational integration into the bilayer. However,
around five percent of human membrane proteins, including
SNAREs, signaling proteins and endoplasmic reticulum (ER)
translocon components, belong to the family of tail-anchored
(TA) proteins. TA proteins are each tethered to their respective
membrane by a single transmembrane domain (TMD) at the
extreme C terminus. This helix, obscured by the ribosome during
translation, is inaccessible to the signal recognition particle
(SRP), which cotranslationally directs most membrane proteins
to the ER translocon for insertion. An alternative method of tar-
geting is thus required and this function was recently ascribed
to a complex of proteins known as GET (for guided entry of
TA-proteins) (Stefanovic and Hegde, 2007; Favaloro et al.,
2008; Schuldiner et al., 2008).
Each of the proteins so far found to participate in the yeast
GET pathway is a relatively recent discovery (see Table 1).
Get1 and Get2 are transmembrane proteins that bind tightly to
each other and recruit Get3 to the ER membrane (Auld et al.,
2006; Schuldiner et al., 2008). Get3 can be isolated from cytosol
in complex with Get4 andGet5 (Jonikas et al., 2009; Chang et al.,
2010). Theoretically, Get3 is in a position to transiently link these
twoGET subcomplexes, which occur at the ERmembrane and in
the cytosol, respectively. Alternatively, Get3 may interact with
Get1/2 or Get4/5 in amutually exclusive fashion.While Get3 itself
is always found as a homodimer and Get4/5 has recently been
shown to contain two copies of each protein (Chartron et al.,
2010), the full stoichiometry of cytosolic and membrane-associ-
ated GET complexes remains to be established. Very recentStructresults from Favaloro et al. (2010) in the mammalian system
show that once TRC40, also known as Asna1—mammalian
Get3 equivalent (Stefanovic and Hegde, 2007, Favaloro et al.,
2008), is fully bound to a TA protein, the TMD can be inserted
into the ER membrane without any further requirement for cyto-
solic factors.
Genetics and biochemical data link Get4/5 with a tetratrico
peptide repeat (TPR)-containing protein, Sgt2 (Jonikas et al.,
2009; Chang et al., 2010; Costanzo et al., 2010; Leznicki
et al., 2010; Battle et al., 2010), which is homologous to a verte-
brate glutamine-rich TPR protein called SGTA with roles in
androgen-receptor signaling (Buchanan et al., 2007) and mitosis
(Winnefeld et al., 2006). Sgt2 also binds to the chaperones
Ssa1&2 (homologs of Hsc70) and Ydj1 (Hsp40/DnaJ-related).
Bat3, which physically interacts with SGTA, is another newly
discovered player in GET-dependent TA protein insertion
(Leznicki et al., 2010). Rabu et al. (2009) delineated three mech-
anisms for TA-membrane insertion (Hsc70/Hsp40, SRP, and
GET), based on current experimental evidence, and these new
data add support to their speculation that these mechanisms
might be closely intertwined.
The central component of the S. cerevisiae GET pathway, an
ATPase formerly known as Arr4 and now called Get3, first
entered the literature in 2003 when Shen et al. described its simi-
larity to a bacterial arsenical resistance factor, ArsA, and its roles
inmetal stress (Shen et al., 2003). It is the only eukaryotic ATPase
member of the SIMIBI (for SRP, MinD, and BioD) class of
NTPases (see Leipe et al. (2002) for a review) that is dominated
by GTPases, including the main player in membrane protein
insertion, the SRP. Prokaryotic ATPases in this class include
ArsA, dethiobiotin synthetase (BioD), and Nitrogenase Iron
Protein (NifH), which all feature the ‘‘deviant P loop’’ with a lysine
in the second position (Koonin, 1993) and offer useful structural
comparisons for the Get3 nucleotide cycle.ure 18, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 897
Table 1. GET Pathway Components
Protein (S. cerevisiae) Size/aa Mammalian Homolog (H. sapiens) % Identity (aa overlap) Properties
Get1 285 Unknown Suggested: WRB protein N/A 25 (60) Membrane CHD5 (coiled-coil)
Get2 235 Unknown N/A Membrane
Get3 354 TRC40/Asna-1 46 (342) SIMIBI ATPase
Get4 312 Conserved edge-expressed protein (CEE) 33 (135) TPR-like
Get5 212 Ubl4a/GDX 33 (77) Ubiquitin-like domain
Sgt2 346 SGTA 36 (202) TPR
Unknown 1126 Bat3 N/A Ubiquitin-like domain BAG domain
Nuclear localization signal
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MinireviewFurther work (Schuldiner et al., 2005; Auld et al., 2006;
Metz et al., 2006; Kao et al., 2007; Lee and Dohlman, 2008)
identified roles for Get3 in Golgi to ER traffic (the original source
of the GET acronym), the ubiquitin-proteasome system, metal
homeostasis, signal transduction, and insulin secretion. Upregu-
lation of TRC40/Asna1, the human homolog of Get3, has been
observed in tuberculosis (Mistry et al., 2007), breast cancers
(Kurdi-Haidar et al., 1998), and ovarian cancer (Hemmingsson
et al., 2009a). Inhibition of Asna1 decreases tumor cell resistance
to platinum-based therapies (Hemmingsson et al., 2009b).
Epistatic miniarray profiling first established the functional and
physical association between Get3 and Get1/2 (Schuldiner
et al., 2005), or Get4/5 (Jonikas et al., 2009) in the context of
protein biogenesis in the ER.
Most of these seemingly disparate functions were collectively
rationalized as the result of Get3’s role in TA-protein insertion
(Stefanovic andHegde, 2007). TAproteins havediverse functions
in membrane fusion, secretion, apoptosis, and quality control of
proteins (for a recent review, see Rabu et al. [2009]) and failure
to insert them has wide-reaching consequences, particularly
under the conditions of cellular stress. These consequences
include defects in removal of terminally misfolded proteins from
the ER (Schuldiner et al., 2005) and impaired DNA damage repair
(Zewail et al., 2003). Get3 is also known to bind other proteins;
e.g., Gpa1 (Lee and Dohlman, 2008) and Gef1 (Metz et al.,
2006), whose relation to TA-protein insertion is uncertain.
Since they enable protein-protein interactions, the TPR/TPR-
like folds of Sgt2 and Get4 suggest that the cytosolic GET
complex may serve as a scaffold to integrate TA biogenesis
with other cellular pathways. It is likely that such coordination
starts upon emergence of the TA-protein substrate from the
ribosome (Rabu et al., 2009). The stress-related phenotypesTable 2. A Summary of Get3 Structures Solved by X-ray Crystallogr
Species Nucleotide Res/A˚ R, Rfree
S. cerevisiae ADP.AlF4
- 2.0 0.178,0.
S. pombe none 3.0 0.240, 0
A. fumigatus ADP 3.2 0.214,0.
C. thermophilum AMPPNP-Mg2+ 3.0 0.230, 0
C. thermophilum ADP-Mg2+ 3.5 0.232, 0
S. cerevisiae none 2.3 0.223, 0
S. cerevisiae none 2.8 0.237,0.
S. cerevisiae ADP 3.0 0.253, 0
898 Structure 18, August 11, 2010 ª2010 Elsevier Ltd All rights reserof the GET pathway mutants imply that a putative interplay
between this pathway and other chaperones becomes essential
when protein biogenesis is jeopardized by unfavorable physico-
chemical conditions.
Structures of Get3
Until September 2009, there was no structural information
available for Get3 or any other GET pathway component.
Concurrent publication in Proceedings of the National Academy
of Sciences (Suloway et al., 2009) and Nature (Mateja et al.,
2009) of Get3 crystal structures, was swiftly followed by three
further papers (Bozkurt et al., 2009; Hu et al., 2009; Yamagata
et al., 2010) that featured ‘‘open’’ and ‘‘closed’’structures from
selected species (summarized in Table 2; examples represented
in Figure 1), providing a variety of nucleotide-bound states and
insights into the mechanism of TA-protein membrane insertion.
Structural Characteristics of Get3
The Get3 structure (see Figure 1) (Suloway et al., 2009; Mateja
et al., 2009; Bozkurt et al., 2009; Hu et al., 2009; Yamagata
et al., 2010) exists as a dimer held together by a zinc ion that is
tetrahedrally coordinated by cysteines 285 and 288 (S. cerevi-
siae numbering in the CXXC motif). The constituent monomer
consists of a nucleotide-binding domain (NBD), which includes
the dimerization interface and a methionine-rich, helical domain
that renders the dimer ‘‘open’’ or ‘‘closed.’’ ‘‘Closing’’ of the Get3
dimer involves the burial of approximately 1,500 A˚ of additional
surface area, accompanied by a 35 rotation of the subunits
toward each other and a concomitant decrease in the distance
between Mg2+-binding sites by over 10 A˚ (Mateja et al., 2009;
Bozkurt et al., 2009; Hu et al., 2009). In both states, the helical
domain connects via a flexible region to the NBD, whose nucle-
otide-bound state appears to influence conformation.aphy
Form Authors PDB
213 closed Mateja et al. (2009) 2WOJ
.288 open Mateja et al. (2009) 2WOO
251 open Suloway et al. (2009) 3IBG
.271 closed Bozkurt et al. (2009) 3IQW
.295 closed Bozkurt et al. (2009) 3IQX
.247 open Hu et al. (2006) 3H84
281 open Yamagata et al. (2010) 3A36
.282 open Yamagata et al. (2010) 3A37
ved
Figure 1. Example GET Structures from
S. cerevisiae
(A) The highest resolution (1.8 A˚) Get3 ‘‘open’’
structure (nucleotide free) (Hu et al., 2009)
is compared with the highest resolution (2 A˚)
‘‘closed’’ Get3 structure (ADP.AlF4
- bound)
(Mateja et al., 2009). The nucleotide is shown in
red, the zinc ion in orange, and the magnesium
ions in green. One of the monomers in each dimer
is colored lilac and the other is colored blue (NBD)
and pink (helical domain).
(B) The structure of Get4 (gold) bound to the
N-terminal domain of Get5 (red) from Chang
et al. (2010). The Get5 Ubl and C-terminal domain
(for dimerization as indicated in Chartron et al.
[2010]) are shown as shapes.
Figure 2. NBD Features
Ribbon diagram of a monomer from an S. cerevisiae Get3 dimer (built out of
coordinates from Yamagata et al. [2010]), highlighting the nucleotide binding
characteristics: the all-parallel 7 strand beta sheet (orange), the ‘‘deviant’’
P loop (green with the rare lysine indicated in stick form), the uniquely orien-
tated Switch I (purple) and Switch II (gray), the A-loop (red), and the CXXCmotif
(yellow with the cysteines shown in stick form). The TRC40 insert, unique to
archeal and eukaryotic versions of this protein, is colored pink.
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MinireviewIn each case, the Get3 unit adopts the following order of
secondary structure elements (13 a helices and 7 b strands)
starting from the N terminus: a1, b1, a2, b2, a3, b3, a4, a5, a6,
b4, a7, a8, a9, b5, a10, b6, a11, b7, a12, a13. The helical domain,
whether ‘‘open’’ or ‘‘closed,’’ is formed from a helices a4 to a9
and includes disordered regions in every published structure.
This reflects conformational flexibility in the helical domain,
which might gain order in the presence of a TMD or other acces-
sory proteins. The NBD is built from all the remaining helices and
strands forming a mixed a-b fold.
The Get3 structure encompasses some canonical features
(highlighted in Figure 2) of the P loop NTPase superfamily
(Koonin, 1993), including an all-parallel 7 strand beta sheet, the
‘‘deviant’’ P loop (or Walker A motif for nucleotide binding with
a rare lysine in the second position) at residues 25-33, a uniquely
orientated Switch I at residues 57-61, and Switch II at residues
166-173. These dynamic switch regions bind the g-phosphate
of ATP through two main-chain hydrogen bonds, forming
a ‘‘loaded spring’’ that is released upon ATP hydrolysis (Gasper
et al., 2009). The A-loop for adenosine recognition occurs at
residues 316-322. A TRC40 insert, which distinguishes eukary-
otic and archeal versions of Get3 from its prokaryotic homologs
(Mateja et al., 2009; Borgese and Righi, 2010) and may have an
important role in TA binding, is found between a7 and a9 of the
helical domain.
TMD-binding
Though we have yet to see an experimentally determined struc-
ture of Get3 bound to a TMD, Mateja et al. (2009), Bozkurt et al.
(2009), and Yamagata et al. (2010) biochemically analyzed the
interaction between Get3 and the TMD from model TA-proteins
Sec61b, Ramp4. and Sec22p, respectively. Moreover, Suloway
et al. (2009) generated a panel of over seventy Get3 mutants to
probe the TMD binding site in vivo.
A thorough mutational analysis was performed by Mateja
et al. (2009), in which 24 hydrophobic amino acids punctuating
the composite groove (formed by the ‘‘closed’’ structure of
Get3) were individually substituted for aspartate residues. EachStructure 18, August 11, 2010of these mutants was tested for binding
to the TMD of Sec61b and relative
ATPase activity in vitro, and was also
screened for its ability to functionally
complement a Dget3 S. cerevisiae strain
in vivo. Thus, Mateja et al. (2009) pin-pointed a region comprising helices a7 and a8, and overlapping
with the ‘‘TRC insert,’’ as the crucial site of TMD binding. These
authors suggest that the exposed hydrophobic surface of
the ‘‘open’’ state is unsuitable for TMD binding, whereas the
‘‘closed’’ form brings together the hydrophobic residues to
create the composite groove.
Suloway et al. (2009) screened a large number of Get3 mutant
plasmids for their ability to rescue the growth defects of a Dget3
yeast strain. By identifying a cluster of ‘‘loss of function’’ muta-
tions, they successfully predicted the ‘‘closed’’ form of Get3
shown byMateja et al. (2009), with a comparable binding groove
for TMDs.
Bozkurt et al. (2009) took a more biophysical approach to
analyzing the Get3-TMD interaction. They first coexpressedª2010 Elsevier Ltd All rights reserved 899
Figure 3. Schematic Representation of Our
Current Understanding of the GET Pathway
Aside from the interaction of TMDs with Get3, we
have no molecular information on modes of
binding between proteins in this pathway. Sche-
matic representations should therefore be inter-
preted as binding events between the pictured
proteins rather than specific regions thereof.
Potential nucleotide binding/hydrolysis steps are
indicated; a detailed description of the possible
ways in which the nucleotide cycle couples to
TA-protein insertion into membranes can be found
in the body of the text.
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Minireviewand copurified Get3 and TA-protein Ramp4, both from
C. thermophilum, and found that the complex did not contain
any nucleotide. They then used amide hydrogen exchange
mass spectrometry (HX-MS) to compare its dynamics with those
of Get3 in the ‘‘open’’ and ‘‘closed’’ states. Ramp4 shielded
amide hydrogens from exchange to deuterons in specific
regions corresponding to helices a7, a8, and a9, and the oppo-
site effect was seen at the end of helix a6.
Yamagata et al. (2010) coexpressed GST-tagged Get3 with
Sec22p and showed that the proteins copurified on a glutathione
column. They replaced nineteen residues between a7 and a9
(and hence most of the ‘‘TRC insert’’) of Get3 with a Gly-Ala-
Ala-Gly linker and found that binding to Sec22p was radically
reduced.
Although data from these three groups are largely consistent,
there is still a lot of missing information on the mode of Get3
binding to TMDs. The inherent flexibility of the helical domain
and its changing conformations offer scope for a complexmech-
anism of TMD association that will become clearer as further
atomic-level information becomes available.
Nucleotide Hydrolysis Cycle
ADP.AlF4
- and AMPPNP-Mg2+ bindingmimic the ATP-hydrolysis
transition state and ATP-bound forms of Get3, respectively, and
adopt the ‘‘closed’’ conformation (Mateja et al., 2009; Bozkurt
et al., 2009). These analogs (and presumably ATP itself) asso-
ciate with both molecules in the Get3 dimer. Each nucleotide
makes several contacts with the P loop and Switch II domain
of the same Get3, while simultaneously binding to the ‘‘deviant’’
lysine 26 of the opposing Get3 molecule in the dimer. The
Switch II region is responsible for several dimer contacts in the
‘‘closed’’ state, where its C-terminal half adopts a helical struc-
ture extending a7 and shortening the preceding loop region. In
the ADP.AlF4
- structure, a water molecule, coordinated by
aspartate 57 in the Switch I domain, is poised for nucleophilic
attack where the g-phosphate would be if ATP, rather than its
analog, were present (Mateja et al., 2009). However, in the900 Structure 18, August 11, 2010 ª2010 Elsevier Ltd All rights reservedAMPPNP-Mg2+ form, switches I and II
are ill defined and not within close enough
proximity for ATP hydrolysis (Bozkurt
et al., 2009).
ADP-bound Get3 occurs in both
‘‘closed’’ (Bozkurt et al., 2009; Hu et al.,
2009) and ‘‘open’’ (Suloway et al., 2009;
Yamagata et al., 2010) versions. In the
latter, each nucleotide discretely con-
tacts one molecule of the dimer, and thea and b phosphate groups of ADP still form hydrogen bonds
with the side chains of threonines 33 and 32, respectively. The
‘‘closed’’ ADP-bound structure described by Bozkurt et al.
(2009) contains a Mg2+ ion coordinating the two helical domains
and occupies the same crystal form as their AMPPNP-Mg2+
version.
All of the reported nucleotide-free Get3 structures exhibit the
‘‘open’’ form (Mateja et al., 2009; Hu et al., 2009; Yamagata
et al., 2010). Since the Get3 structures exhibit differences and
the helical domains always include poorly resolved areas, the
question of ‘‘open’’ and ‘‘closed’’ forms remains an area for
debate. There could well be intermediate forms and structural
variation relating to which point in the mechanism is captured
and which accessory proteins are found bound.
Each of the Get3 papers suggests a putative mechanistic
model (summarized in Figure 3) for the correlation of TA-protein
insertion with Get3 nucleotide binding and hydrolysis. Suloway
et al. (2009), Mateja et al. (2009), and Bozkurt et al. (2009) spec-
ulate that ATP-binding first closes the Get3 dimer, increasing its
affinity for TA proteins. Hu et al. (2009) propose that TA proteins
might first bind to an ‘‘open’’ nucleotide-free Get3 with ATP
binding then closing Get3 around the TMD in a protective
fashion. Yamagata et al. (2010) suggest Get3 exists in equilib-
rium between ‘‘open’’ and ‘‘closed’’ states and that binding
to TA proteins plus membrane recruitment to Get1/2 is what
stabilizes the closed form. All agree that the Get3-TA protein
docks onto the membrane-bound receptor complex Get1/2
and that ATP hydrolysis dissociates Get3 from the membrane,
probably resuming its ‘‘open’’ form and releasing the TA protein
for membrane insertion. Bozkurt et al. (2009) observed some
TA-protein membrane insertion without a requirement for ATP
hydrolysis and therefore speculate that the docking of Get3/
TMD and TA-protein insertion could precede ATP hydrolysis,
which may be necessary to trigger release of the ‘‘open’’ form
of Get3 from the Get1/2 receptor. Further investigations are
required to truly delineate this mechanism.
Structure
MinireviewStructures of Get4 and Get5
January 2010 saw the publication (Chang et al., 2010) of the first
structural information on other members of the GET pathway
with a crystal structure of S. cerevisiae Get4 in complex with the
N-terminal domain of Get5. Bozkurt et al. (2010) have now also
solved the structure of C. thermophilum Get4 in isolation. Char-
tron et al. (2010) most recently revealed a structure of Get4 with
the N-terminal of Get5 in a different crystal form with the added
information that the complex exists as a dimer (two copies of
Get4 and two copies of Get5 connected via the C-terminal
domains of Get5). Moreover, via mutagenesis, they identified the
Get4/5 binding interface with Get3, which occurs at the positive
N-terminal face of Get4, confirming the prediction of Bozkurt
et al. (2010). Get5 consists of an ubiquitin-like domain (Ubl),
whose human homolog (Ubl4a/GDX) was structurally solved by
NMR (PDBID: 2DZI), surrounded by N- and C-terminal domains.
All three papers agree that Get4 forms an a-2-solenoid fold
with resemblance to a TPR. The structures overlap with a low
rmsd, indicating that only minor structural changes occur in
Get4 upon binding to Get5. The concave face of Get4 displays
little conservation but the convex surface includes two potential
binding pockets and the charged patch near the N terminus,
which binds to Get3 (Bozkurt et al., 2010). Get5N wraps snugly
around Get4 so it is curious that mammalian forms of Get5
lack this domain. Chartron et al. (2010) suggest that, in higher
eukaryotes, Get5N may be replaced with a separate protein
that bridges Ubl4a with the pertinent Get4 equivalent. Both clefts
on the convex body of Get4 are occupied by Get5 helices in the
structure of the complex or by C-terminal helices from Get4 in
the structure of Get4 alone, indicating their potential flexibility
for mechanistic changes in protecting and passing on TMDs of
TA proteins. This arrangement also offers dynamic possibilities
for the changing composition of the GET subcomplexes, both
with currently identified GET proteins, and those members and
accessory proteins that may still elude us.
Perspectives and Outlook
In vitro TA-protein insertion assays into rough microsomal
membranes consistently showed that a membrane-bound
receptor is required for the insertion of Get3/TRC40-dependent
substrates (Stefanovic and Hegde, 2007; Favaloro et al., 2008;
Schuldiner et al., 2008; Bozkurt et al., 2009), in addition to the
roles played by Get3, 4, and 5. This is likely the unidentified
mammalian counterpart of the yeast Get1/2 receptor, which still
evades structure determination by any method. Structure
prediction algorithms (Kelley and Sternberg, 2009) indicate that
both Get1 and Get2 consist of multiple transmembrane helices
that present extreme challenges to the structural biologist.
Both proteins also exhibit coiled-coil forming, cytoplasmic
domains on the ER membrane that are credible sites of binding
to Get3. These, along with Bat3 and Sgt2, are an obvious next
step for structural studies.
Several other proteins display interactions with Get3 that
await structural characterization. In 2008, Lee and Dohlman
reported binding of Get3 to Gpa1, the alpha subunit of a phero-
mone-activated heterotrimeric G protein in S. cerevisiae. Their
further characterization revealed that Get3 acts as a ‘‘nonrecep-
tor guanine nucleotide exchange factor’’ (nrGEF), stabilizing the
nucleotide-free form of the subunit. Metz et al. (2006) describedStructthe copper-dependent interaction betweenGet3 and an intracel-
lular CLC (voltage-gated chloride channel) chloride-transport
protein, Gef1. Further study of these binding proteins, including
structural work, will clarify whether the interactions reflect inde-
pendent cellular roles for Get3 or if they link in with TA-protein
biogenesis.
All of the currently available GET structures were solved by
X-ray crystallography. The evident flexibility and dynamics of
the GET proteins also make them a potentially interesting target
for NMR spectroscopy studies, in particular the exciting new
methods that have been developed for the study of larger
proteins (Isaacson et al., 2007; Xu et al., 2009). In both ‘‘open’’
and ‘‘closed’’ crystal structures of Get3, selected helices in the
helical domain and at the junction between the two domains
are missing or ill defined, probably due to conformational diver-
sity. This region is an obvious site for examination by NMR,
which could be used tomap the binding to TMDs at residue-level
detail as well as probing the nucleotide hydrolysis cycle. More-
over, if it is possible to purify intact combinations of GET proteins
from yeast, containing either the cytosolic or membrane-
associated components, it could be a viable target for electron
microscopy, potentially revealing a three-dimensional view of
the complex with information on its composition, arrangement,
and stoichiometry.
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